Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with <i>Clostridioides difficile</i> infection with and without sepsis.

Amin, Alpesh; Nelson, Winnie W; Dreyfus, Jill; Wong, Anny C; Mohammadi, Iman; Teigland, Christie; Dahdal, David N; Feuerstadt, Paul

Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with Clostridioides difficile infection with and without sepsis.

Amin, Alpesh; Nelson, Winnie W; Dreyfus, Jill; Wong, Anny C; Mohammadi, Iman; Teigland, Christie; Dahdal, David N; Feuerstadt, Paul.

Afiliación

Amin A; UCI Medical Center, 101 The City Drive, City Tower, Suite 500, Orange, CA 92868, USA.
Nelson WW; Ferring Pharmaceuticals Inc., Parsippany, NJ, USA.
Dreyfus J; Avalere Health, Washington, DC, USA.
Wong AC; Avalere Health, Washington, DC, USA.
Mohammadi I; Avalere Health, Washington, DC, USA.
Teigland C; Avalere Health, Washington, DC, USA.
Dahdal DN; Ferring Pharmaceuticals Inc., Parsippany, NJ, USA.
Feuerstadt P; PACT Gastroenterology Center, Hamden, CT, USA.

Ther Adv Infect Dis ; 9: 20499361221095679, 2022.

Article en En | MEDLINE | ID: mdl-35510091

Palabras clave

Clostridioides difficile; Clostridium difficile infection; Medicare; cost; healthcare resource utilization; recurrent CDI; sepsis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Observational_studies Idioma: En Revista: Ther Adv Infect Dis Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google